We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.1B
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+4.68%
3 Year Est. Return
+8.24%
5 Year Est. Return
+32.95%
10 Year Est. Return
AUM
$2.72B
AUM Growth
+$1.26B
Cap. Flow
+$343M
Cap. Flow %
12.61%
Top 10 Hldgs %
63.11%
Holding
138
New
54
Increased
15
Reduced
11
Closed
39

Sector Composition

1 Healthcare 7.19%
2 Technology 4.86%
3 Communication Services 2.17%
4 Materials 1.3%
5 Financials 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATTU
26
DELISTED
Attunity Ltd
ATTU
$10.6M 0.39%
+450,000
New +$10M
TRCO
27
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$10.4M 0.38%
225,000
-22,129
-9% -$1.02M
OAK
28
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$10.1M 0.37%
+204,000
New +$8.86M
LEXEA
29
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$10.1M 0.37%
+235,000
New +$10.1M
PACB icon
30
Pacific Biosciences
PACB
$447M
$10.1M 0.37%
1,390,000
-343,340
-20% -$2.48M
ARRS
31
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$8.56M 0.32%
270,900
MLNX
32
DELISTED
Mellanox Technologies, Ltd.
MLNX
$8.29M 0.31%
+70,000
New +$7.04M
LBTYA icon
33
Liberty Global Class A
LBTYA
$3.52B
$7.48M 0.28%
300,000
+30,217
+11% +$739K
NAVG
34
DELISTED
Navigators Group Inc
NAVG
$7.44M 0.27%
106,478
-8,467
-7% -$591K
TVRD
35
CALL
Tvardi Therapeutics
TVRD
$30M
$6.93M 0.26%
+9,797
New +$5.86M
TVTX icon
36
PUT
Travere Therapeutics
TVTX
$5.27B
$6.01M 0.22%
+265,600
New +$5.87M
ELV icon
37
PUT
Elevance Health
ELV
$80.9B
$5.74M 0.21%
+20,000
New +$5.78M
NITE
38
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$4.59M 0.17%
+181,075
New +$3.2M
STC icon
39
Stewart Information Services
STC
$2.19B
$4.42M 0.16%
103,638
ELLI
40
DELISTED
Ellie Mae Inc
ELLI
$4.24M 0.16%
+42,935
New +$3.73M
SIFI
41
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
$4.18M 0.15%
323,436
+37,236
+13% +$509K
IMDZ
42
DELISTED
Immune Design Corp.
IMDZ
$3.51M 0.13%
+600,030
New +$2.04M
WBC
43
DELISTED
WABCO HOLDINGS INC.
WBC
$3.44M 0.13%
+26,112
New +$3.22M
IMGN
44
PUT
DELISTED
Immunogen Inc
IMGN
$3.35M 0.12%
+1,239,500
New +$5.37M
IMGN
45
DELISTED
Immunogen Inc
IMGN
$3.21M 0.12%
+1,186,300
New +$5.14M
FOXA icon
46
Fox Class A
FOXA
$24.2B
$3.02M 0.11%
+82,349
New +$3.21M
BMRN icon
47
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.97M 0.11%
33,400
+23,000
+221% +$2.13M
BCRX icon
48
PUT
BioCryst Pharmaceuticals
BCRX
$2.36B
$2.93M 0.11%
+359,600
New +$3.08M
BCRX icon
49
CALL
BioCryst Pharmaceuticals
BCRX
$2.36B
$2.9M 0.11%
+355,800
New +$3.05M
TIER
50
DELISTED
TIER REIT, Inc.
TIER
$2.87M 0.11%
+100,000
New +$2.37M

Similar funds

DLD Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, DLD Asset Management held 138 positions worth $2.72B, up 86% from $1.46B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

DLD Asset Management deployed $343M of net new capital in Q1 2019, opening 54 new positions and adding to 15 existing holdings. Its largest new stake was Biogen: 346,700 shares worth $82M.

By sector, the portfolio is most concentrated in Healthcare at 7.2% of assets, up from 4.4% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Qualcomm, an estimated $62.5M trimmed.

  • DLD Asset Management's largest Q1 2019 buy was Biogen: 346,700 shares worth $82M.
  • DLD Asset Management added most to L3 Technologies, Inc. in Q1 2019, an estimated $9.9M increase.
  • DLD Asset Management's biggest Q1 2019 reduction was Qualcomm, cutting an estimated $62.5M.
  • DLD Asset Management fully exited Shire pic in Q1 2019, selling an estimated $38M.
  • DLD Asset Management's ten largest holdings make up 63% of its $2.72B portfolio in Q1 2019.
  • DLD Asset Management opened 54 new positions and closed 39 in Q1 2019.
  • DLD Asset Management's portfolio value rose 86% quarter-over-quarter to $2.72B.

Based on DLD Asset Management's 13F filing for Q1 2019, filed 14 May 2019.